| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Feb 3, 2025 | Altimmune, Inc. | Chief Medical Officer | Sell | 22.5 | -6,085 | -1.97% | ✗ | $54.2K |
| Jan 25, 2025 | Jan 28, 2025 | Altimmune, Inc. | Chief Medical Officer | Sell | 26.3 | -4,994 | -7.16% | ✗ | $34.9K |
| Feb 1, 2024 | Feb 5, 2024 | Altimmune, Inc. | Chief Medical Officer | Sell | 26.3 | -4,133 | -3.90% | ✗ | $39.5K |
| Jan 30, 2024 | Feb 1, 2024 | Altimmune, Inc. | Chief Medical Officer | Sell | 78.8 | +548 | 1.27% | ✗ | $26.5K |
| Mar 23, 2023 | Mar 23, 2023 | Altimmune, Inc. | Chief Medical Officer | Buy | 91.3 | +10,000 | 42.90% | ✗ | $42.2K |
| Feb 2, 2023 | Feb 6, 2023 | Altimmune, Inc. | Chief Medical Officer | Sell | 26.3 | -2,364 | -9.21% | ✗ | $35.6K |
| Jan 31, 2023 | Feb 2, 2023 | Altimmune, Inc. | Chief Medical Officer | Sell | 26.3 | -887 | -2.71% | ✗ | $30.1K |
| Feb 28, 2022 | Mar 2, 2022 | Altimmune, Inc. | Chief Medical Officer | Sell | 10.0 | -30,000 | -72.21% | ✓ | $225.6K |
| Jan 31, 2022 | Feb 3, 2022 | Altimmune, Inc. | Chief Medical Officer | Sell | 26.3 | -383 | -1.97% | ✗ | $17.4K |
| Nov 12, 2020 | Nov 13, 2020 | Altimmune, Inc. | Director | Sell | 13.8 | -4,015 | -49.67% | ✓ | $40.2K |